Education
About Us
Working with TipRanks
Follow Us
Maria Freire Insider Profile
4 Followers
Maria Freire, Director at Alexandria Equities, holds 6.82K shares in Biogen (Ticker: BIIB), holds 100.82K shares in Exelixis (Ticker: EXEL), holds 7.45K shares in Alexandria Equities (Ticker: ARE).
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
-14.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Maria Freire holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 01, 2022 - Aug 01, 2023
Return:+22.80%
The most profitable trade made by Maria Freire
Maria Freire's Trading History
Alexandria Equities
Jan 17, 2025
Director
Uninformative Buy
―
$582.60K
Exelixis
May 30, 2025
Director
Uninformative Buy
―
$4.48M
Biogen
Jun 18, 2025
Director
Uninformative Buy
―
$851.81K
List of latest transactions for each holding click on a transaction to see Maria Freire's performance on stock
You May Also Like
Maria Freire insider profile FAQ
What is the percentage of profitable transactions made by Maria Freire?
The percentage of profitable transactions made by Maria Freire is 33%.
What is the average return per transaction made by Maria Freire?
The average return per transaction made by Maria Freire is -14.70%.
What stocks does Maria Freire hold?
Maria Freire holds: ARE, EXEL, BIIB stocks.
What was Maria Freire’s latest transaction?
Maria Freire latest transaction was an Uninformative Buy of ―.
What was Maria Freire's most profitable transaction?
Maria Freire’s most profitable transaction was an Informative Sell of ARE stock on August 1, 2022. The return on the trade was 22.80%.
What is Maria Freire's role in Alexandria Equities?
Maria Freire's role in Alexandria Equities is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.